Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep196 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Combined vildagliptin + metformin therapy can increase telomerase activity in patients with type 2 diabetes

Dudinskaya Ekaterina , Matchekhina Lubov , Strazhesko Irina , Tkacheva Olga

IntroductionMetformin and vildagliptin are the medications amongst first-line treatment options in type 2 diabetes patients. Few recent studies have explained positive pleotropic effects of metformin therapy by telomerase activation and telomeres length in leukocytes preservation. Knowing the primary role of insulin-signalling pathway in insulin resistance development and physiology of ageing, it is possible to suggest, that one of the protective mechani...

ea0037gp.12.05 | Diabetes and obesity – Translational diabetes | ECE2015

Telomere biology and vascular ageing in patients with T2DM

Brailova Nataliia , Dudinskaya Ekaterina , Strazhesko Irina , Akasheva Dariga , Pokrovskaya Marina , Tkacheva Olga , Boytsov Sergei , Shestakova Marina , Vigodin Vladimir

It is known that glucose disturbances contribute to vascular ageing. The length of telomere (TL) and telomerase activity (TA) are considered as biomarkers of cellular ageing. It is crucial to determine the role of telomere biology in different vessels changes in diabetic patients. The aim of our study was to determine the role of telomere biology in vascular ageing in patients with T2DM.Results: All patients were divided into two groups by the median of ...